Silver Book Fact

Glycoprotein inhibitors have been shown to reduce the risk of death, a second heart attack, or the need for revascularization by 48% to 52% in patients who have suffered a first heart attack.

MEDTAP International, Inc. The Value of Investment in Health Care: Better care, better lives. Bethesda, MD: MEDTAP; 2004. http://www.aha.org/content/00-10/08affordability-value.pdf

Reference

Title
The Value of Investment in Health Care: Better care, better lives
Publisher
MEDTAP
Publication Date
2004
Authors
MEDTAP International, Inc
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Human Value

Related Facts

  • The development of antioxidants that reduce oxidative damage is underway. One antioxidant that has been found, uric acid, has an even greater protective effect when combined with tPA.  
  • Every additional dollar spent on the routine use of beta-blockers (versus under-use) in acute heart attack patients has produced health gains valued as high as $38.44.  
  • 277 medicines are currently in development to treat or prevent heart disease and stroke.  
  • Assuming that Medicare Part D covers about 37% of beneficiaries’ drug costs, it is estimated that providing post-myocardial infarction Medicare beneficiaries with full coverage for combination pharmcotherapy will save more…  
  • t-PA cost savings
    The total annual benefit to society from t-PA use in the United States is around $363 million—$60 million in direct cost savings to society plus an additional 7,510 QALYs. This means…